Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Hübbe M"'
Autor:
Ma, Clara-Altamirano, Dy, García-Ortega, Núñez-González M, Chs, Caro-Sánchez, Espejo-Sánchez G, Martínez-Said H, Cuéllar-Hübbe M
Publikováno v:
Europe PubMed Central
Chondrosarcoma is the second most frequent primary malignant bone tumor, is characterized by the formation of a chondroid matrix, is more frequent in advanced ages and its prognosis is directly related to the histological subtype and tumor grade. The
Autor:
Clara-Altamirano, M. A., García-Ortega, D. Y., Núñez-González, M., Caro-Sánchez, C. H. S., Espejo-Sánchez, G., Martínez-Said, H. l., Cuéllar-Hübbe, M.
Publikováno v:
Acta Ortopédica Mexicana; Jul/Aug2021, Vol. 35 Issue 4, p303-304, 5p
Autor:
Aaboe Jørgensen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Ugel S; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Linder Hübbe M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Carretta M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Perez-Penco M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Kopp K; IO Biotech ApS, Copenhagen, Denmark., Chapellier M; IO Biotech ApS, Copenhagen, Denmark., Adamo A; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., De Sanctis F; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Frusteri C; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Iezzi M; Center for Advanced Studies and Technology (CAST), Department of Neurosciences Imaging and Clinical Sciences, University of G. D'Annunzio of Chieti-Pescara, Chieti, Italy., Zocca MB; IO Biotech ApS, Copenhagen, Denmark., Hargbøll Madsen D; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Wakatsuki Pedersen A; IO Biotech ApS, Copenhagen, Denmark., Bronte V; Immunology Section, Department of Medicine, University of Verona, Verona, Italy., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. mads.hald.andersen@regionh.dk.; IO Biotech ApS, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Nov; Vol. 9 (11), pp. 1316-1326. Date of Electronic Publication: 2021 Sep 13.
Autor:
Clara-Altamirano MA; Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México., García-Ortega DY; Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México., Núñez-González M; Instituto Nacional de Rehabilitación «Dr. Luis Guillermo Ibarra Ibarra». Av. México-Xochimilco 289, C.P. 14389. Ciudad de México. México., Caro-Sánchez CHS; Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México., Espejo-Sánchez G; Hospital de Alta Especialidad de Veracruz. Veracruz, México., Martínez-Said H; Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México., Cuéllar-Hübbe M; Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México.
Publikováno v:
Acta ortopedica mexicana [Acta Ortop Mex] 2021 Jul-Aug; Vol. 35 (4), pp. 300-304.
Autor:
Yi, Ming1,2 (AUTHOR), Li, Tianye3 (AUTHOR), Niu, Mengke4,5 (AUTHOR), Wu, Yuze5 (AUTHOR), Zhao, Bin1 (AUTHOR), Shen, Zhuoyang1 (AUTHOR), Hu, Shengtao1 (AUTHOR), Zhang, Chaomei1 (AUTHOR), Zhang, Xiaojun2 (AUTHOR), Zhang, Jing6 (AUTHOR), Yan, Yongxiang6 (AUTHOR), Zhou, Pengfei6 (AUTHOR), Chu, Qian5 (AUTHOR) qianchu@tjh.tjmu.edu.cn, Dai, Zhijun1 (AUTHOR) dzj0911@126.com, Wu, Kongming2,5 (AUTHOR) kmwu@tjh.tjmu.edu.cn
Publikováno v:
Advanced Science. 11/20/2024, Vol. 11 Issue 43, p1-20. 20p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yamada, Yoshiki1,2 (AUTHOR), Wakamatsu, Toru1,2 (AUTHOR) evolutionhhh49@yahoo.co.jp, Imura, Yoshinori1,2 (AUTHOR), Tamiya, Hironari1,2 (AUTHOR), Yagi, Toshinari1 (AUTHOR), Suzuki, Rie1,2 (AUTHOR), Inoue, Akitomo1,2 (AUTHOR), Takami, Haruna1,2 (AUTHOR), Nakai, Sho1,2 (AUTHOR), Outani, Hidetatsu2 (AUTHOR), Kakunaga, Shigeki1,2 (AUTHOR), Takenaka, Satoshi1,2 (AUTHOR)
Publikováno v:
World Journal of Surgical Oncology. 10/5/2024, Vol. 22 Issue 1, p1-9. 9p.
Autor:
García-Ortega DY; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico. Electronic address: dgarciao@incan.edu.mx., Álvarez-Cano A; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico., Sánchez-Llamas LA; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico., Caro-Sanchez CHS; Department of Pathology, National Cancer Institute Mexico City, Mexico., Martínez-Said H; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico., Luna-Ortiz K; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico., Cuéllar-Hübbe M; Departent of Surgical Oncology, National Cancer Institute Mexico City, Mexico.
Publikováno v:
Surgical oncology [Surg Oncol] 2018 Sep; Vol. 27 (3), pp. 551-555. Date of Electronic Publication: 2018 Jul 18.
Publikováno v:
Journal of Infection in Developing Countries. Jun2024, Vol. 18 Issue 6, p932-936. 5p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.